Lower Drug Spend and Healthcare Costs to Improve the Pharmaceutical Industry with Chris Ford, Assistant Vice President of Strategy and Innovation at Prime Therapeutics

It all comes back to the need for collaboration and the need for value.

In this episode, Kyle Wildnauer-Haigney speaks with Chris Ford, Assistant Vice President of Strategy and Innovation at Prime Therapeutics, about his work to bring collaboration and value to lower drug spend and healthcare costs for stakeholders within the PBM and Specialty Pharmacy space. Chris also mentions finding unique solutions that deliver on the quadruple aim. He talks about what differentiates Prime Therapeutics from other PBMs and why there’s a need for better infrastructure and collaboration between providers and payers to have a long-term sustainable drug delivery system that provides good financial value, clinical outcomes, and patient experience. He explains why this lack can drive specialty medications prices to rise sky-high and what foundational work can be done to achieve a solution. 

Tune in to learn more about the work and actions required to improve the drug distribution ecosystem!

Click this link to show notes, transcripts, and resources: outcomesrocket.health